TF and breast carcinoma: Providing further support for the galectin-1 TF antigen interaction as a significant pathway in cancer cell aggregation, Glinsky et al. observed the interaction of galectin-1 with the TF-antigen on MDA-MB-435 breast cancer cells [92].